Physician profile
Owen Capocyan
NPI 1063695328
$1,476.25
in general payments reported to CMS, 2019-2025
23 companies · $75.82 in 2025
The $75.82 reported for 2025 was less than what a typical Geriatric Medicine (Family Medicine) provider received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2020: $332 · 2021: $26.03 · 2022: $195 · 2023: $187 · 2024: $386 · 2025: $75.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $648.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $392.55 | 2023-2025 | |
| Amgen INC. | $166.52 | 2020-2024 | Krystexxa |
| Astrazeneca Pharmaceuticals LP | $136.57 | 2019-2022 | |
| Astellas Pharma US INC | $124.59 | 2019-2023 | Veozah |
| Horizon Therapeutics Plc | $105.63 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $103.11 | 2020 | |
| Aimmune Therapeutics, INC. | $73.26 | 2024 | |
| Janssen Pharmaceuticals, INC | $64.00 | 2020-2023 | Xarelto |
| Lundbeck LLC | $41.57 | 2024 | Rexulti |
| Nestle Healthcare Nutrition INC. | $39.17 | 2023 | |
| Allergan, INC. | $25.78 | 2019 | |
| Lilly USA, LLC | $21.31 | 2022 | |
| Eisai INC. | $21.11 | 2020 | |
| Hologic Sales and Service, LLC | $18.22 | 2022 | |
| Mylan Pharmaceuticals INC. | $17.74 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $17.59 | 2024 | Rexulti |
| Pfizer INC. | $17.41 | 2019 | |
| Acadia Pharmaceuticals INC | $17.28 | 2020 | |
| Exact Sciences Corporation | $16.62 | 2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $15.64 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.00 | 2022 | |
| Vivus LLC | $13.79 | 2021 | |
| Novo Nordisk INC | $12.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Owen Capocyan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.